China launches a groundbreaking open-source artificial intelligence framework designed to democratize DNA screening and genetic analysis. This innovative tool aims to accelerate the diagnosis and understanding of rare genetic disorders while ensuring equitable access to cutting-edge precision medicine technology across different populations and socioeconomic backgrounds. The initiative represents a significant step toward making advanced genomic healthcare more accessible globally.

Summary auto-generated by AI from the original publisher's content. Editorial standards.